Massachusetts regulators have ordered all pharmacists and pharmacy technicians who worked at the Framingham company at the center of national fungal meningitis outbreak to immediately stop working in the drug-compounding industry.
The letter dated Oct. 31 from the Massachusetts Board of Registration in Pharmacy says the investigation into the outbreak has determined that pharmacists and pharmacy technicians employed by the New England Compounding Center “may present an immediate or serious threat to the public health, safety, and welfare and should immediately cease.”
The letter was obtained by The Boston Globe.
The company closed last month and recalled all of its products. A steroid produced at the company has been linked to 419 fungal meningitis cases and joint infections and 30 deaths, according to the Centers for Disease Control and Prevention.
Was this article valuable?
Here are more articles you may enjoy.
Gas-Guzzler Revival Risks Dead-End Future for US Automakers
Judge Upholds $243M Verdict Against Tesla Over Fatal Autopilot Crash
Claims Handling Breakdowns From LA Wildfires One Year on
Moody’s: LA Wildfires, US Catastrophes Drove Bulk of Global Insured Losses in 2025